MyoDys45-55(MyoGene Bio LLC)

N/A

Report date: 2024/09/29 16:11:13

Base Information

Drug NameMyoDys45-55(MyoGene Bio LLC)
Drug Alias NameDuchenne muscular dystrophy gene therapy(MyoGene Bio LLC)MyoDys45-55(MyoGene Bio LLC)
ClassificationCell and gene therapy > Gene therapy > Gene editing > CRISPR > CRISPR-Cas9
Mechanisms of ActionDystrophin expression stimulantsGene transference
TargetsDystrophin
Therapy Area/IndicationsMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMyoGene Bio LLC
China Registration ClassN/A

Develop Information

Active CompaniesMyoGene Bio LLC
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophy, Duchenne
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A